The Pfizer-Mylan deal is not quite as it appears - STAT

The Pfizer-Mylan deal is not quite as it appears - STAT

The Pfizer-Mylan deal is not quite as it appears

By MATTHEW HERPER

RUBY WALLAU FOR STAT

It’s easy to see what Mylan investors like about the newly announced deal. But they might not like what could come later on.

READ MORE